Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Aclaris Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +8 vs. Q1 2022
- Shares held
- 63.3M
- +4.10M (+6.9%) vs. Q1 2022
- Total value
- $883.3M
- −$136.5M (−13.4%) vs. Q1 2022
- New holders
- 17
- 47 more added
- Sold out
- 9
- 27 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 1,568 | $22.0K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,000 | $14.0K | 0.00% | +1,000 | New |
| Parallel Advisors, LLC | 624 | $9.00K | 0.00% | +24+4.0% | Added |
| Northwestern Mutual Wealth Management Co | 500 | $7.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 347 | $5.00K | 0.00% | −2,790−88.9% | Reduced |
| Truvestments Capital LLC | 298 | $4.00K | 0.00% | +298 | New |
| Lindbrook Capital, LLC | 208 | $3.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 248 | $3.00K | 0.00% | +69+38.5% | Added |
| Massmutual Trust Co FSB | 55 | $1.00K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 84 | $1.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 61 | $1.00K | 0.00% | +61 | New |
| CWM, LLC | 16 | $0 | 0.00% | +16 | New |
| Glassman Wealth Services | 16 | $0 | 0.00% | +16 | New |
| Covestor Ltd | 14 | $0 | 0.00% | +14 | New |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −209,636−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −29,100−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −12,482−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −12,124−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −7,726−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |